YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

PPH
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

seekingalpha.comPOSITIVO

Personal imports of cheaper prescription drugs will soon get trickier

[Different Sizes of Empty Prescription Bottles stock photo] FatCamera/E+ via Getty Images Millions of Americans use mail-order pharmacies from Canada and other countries to personally import medication for a fraction of the U.S. cost. That…

finance.yahoo.comPOSITIVO

VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?

The primary distinction between VanEck Pharmaceutical ETF (NASDAQ:PPH) and VanEck Biotech ETF (NASDAQ:BBH) lies in their industry concentration and risk profiles, as one targets stable pharmaceutical leaders while the other focuses on biot…

finance.yahoo.comPOSITIVO

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

The iShares U.S. Pharmaceuticals ETF (IHE) was launched on May 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market. While an excellent vehicle fo…

finance.yahoo.comPOSITIVO

PPHE Hotel Group Ltd (LSE:PPH) (H1 2026) Earnings Call Highlights: Strategic Review Ends ...

This article first appeared on GuruFocus. Release Date: August 27, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points PPHE Hotel Group Ltd (LSE:PPH) reported solid half…

finance.yahoo.comPOSITIVO

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck MRK and Moderna MRNA delivered a significant breakthrough in melanoma treatment, with their jointly developed mRNA cancer vaccine showing positive results in its first-ever Phase 3 trial. This vaccine, combined with Merck's exemplary…

finance.yahoo.comPOSITIVO

Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus

The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) provides broad, low-cost exposure to the entire healthcare sector, whereas the VanEck Pharmaceutical ETF (NASDAQ:PPH) offers a concentrated, higher-yielding focus on global pharmaceuti…

seekingalpha.comPOSITIVO

SA Asks: What are the most promising oncology companies right now?

[Patients Receiving Medical Infusions in a Clinical Setting with Nurse Assistance] FatCamera/iStock via Getty Images Earlier this week, shares of Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and partner Merck (MRK [https://seeking…

seekingalpha.comNEUTRAL

SA Asks: How could Trump's new executive order impact vaccine makers?

[Merck & Co. headquarters in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images Earlier this month, President Donald Trump announced an executive order aimed at changing the number and timing of vaccines recommended for c…

finance.yahoo.comPOSITIVO

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

Quick Read Merck surged 44% YTD, topping Amgen's 35%, and it achieved the sector's top performance through oncology and newer launches rather than a GLP-1 obesity franchise. Pfizer's 6.3% dividend yield keeps income investors holding despi…

finance.yahoo.comPOSITIVO

Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?

The VanEck Pharmaceutical ETF (NASDAQ:PPH) offers concentrated exposure to established global drugmakers and higher yields, while the State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides a diversified, higher-volatility play on smaller…

finance.yahoo.comPOSITIVO

PPH vs. IYH: Which Healthcare Fund Is the Better Buy?

Investors looking at the VanEck Pharmaceutical ETF (NASDAQ:PPH) and the iShares U.S. Healthcare ETF (NYSEMKT:IYH) are really deciding between a concentrated bet on drugmakers and broad exposure to the entire domestic medical ecosystem. Bot…

finance.yahoo.comPOSITIVO

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?

VanEck Pharmaceutical ETF (NASDAQ:PPH) provides lower-cost exposure to established drug manufacturers with lower historical volatility, while Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) targets high-growth biotech companies at a highe…

seekingalpha.comPOSITIVO

SA Asks: What's the outlook for Big Pharma M&A?

[Medical research with pipette and test tube, DNA analysis, biotechnology, genetic science and healthcare] jittawit.21 Big Pharma moved back into the spotlight last week following a Financial Times report that Bristol Myers Squibb (BMY [ht…

seekingalpha.comPOSITIVO

Most and least shorted mid- to mega-cap healthcare stocks at the end of July

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Short interest data from late July 2026 highlights deeply divided investor sentiment across the healthcare sector. St…

nasdaq.comPOSITIVO

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

Key Points The State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and higher assets under management than the VanEck Pharmaceutical ETF VanEck Pharmaceutical ETF focuses exclusively on pharmaceutical…

finance.yahoo.comPOSITIVO

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

The VanEck Pharmaceutical ETF (NASDAQ:PPH) provides concentrated exposure to drugmakers, while the State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) offers a broader, lower-cost gateway to the entire healthcare sector. The heal…

nasdaq.comPOSITIVO

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ

Key Points The iShares Global Healthcare ETF provides broader exposure with 110 holdings across various sub-sectors compared to the 26 positions in the VanEck Pharmaceutical ETF The VanEck Pharmaceutical ETF features a lower expense ratio…

seekingalpha.comPOSITIVO

Pharmaceuticals still a defensive play amid AI and geopolitical anxieties – analyst

[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Rajesh Kumar, head of European Life Sciences & Healthcare Equity Research at HSBC, positioned healthcare (XLV [https://seekingalpha.com/symbol/XLV]) as a de…

finance.yahoo.comPOSITIVO

For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?

The iShares Global Healthcare ETF (NYSEMKT:IXJ) provides broad global sector exposure, while VanEck Pharmaceutical ETF (NASDAQ:PPH) offers a more concentrated, higher-yielding approach specifically focused on pharmaceutical companies. Thes…

seekingalpha.comPOSITIVO

Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q2

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (XLV [https://seekingalpha.com/symbol/XLV]), which tracks the health car…

finance.yahoo.comPOSITIVO

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on May 1, 2006. Retail and institutional…

nasdaq.comPOSITIVO

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

Key Points Vanguard Health Care ETF provides broad exposure to the health care sector, while the VanEck Pharmaceutical fund offers a highly concentrated portfolio. Vanguard's ETF is significantly more cost-effective, with a 0.09% expense r…

finance.yahoo.comPOSITIVO

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

VanEck Pharmaceutical ETF (NASDAQ:PPH) offers concentrated exposure to global drugmakers, while Vanguard Health Care ETF (NYSEMKT:VHT) provides a much broader, lower-cost entry point into the diverse healthcare landscape. Both funds target…

finance.yahoo.comPOSITIVO

4 ETF Winners of June Likely to Gain in July

Wall Street delivered a strong performance over the past month (as of July 3, 2026). State Street SPDR S&P 500 ETF Trust SPY has gained about 1%, the Nasdaq-100-based Invesco QQQ Trust, Series 1 QQQ has added about 1.1% and the State Stree…

nasdaq.comPOSITIVO

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Key Points The VanEck Pharmaceutical ETF provides a lower expense ratio and a more substantial dividend yield than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF delivered higher 1-year total returns but has lagged the Va…

finance.yahoo.comPOSITIVO

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

The VanEck Pharmaceutical ETF (NASDAQ:PPH) offers a more cost-efficient entry point and higher income potential, while the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) has recently demonstrated stronger price appreciation for investors seekin…

finance.yahoo.comPOSITIVO

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005. While an excellent vehicle for long te…

finance.yahoo.comPOSITIVO

Lilly, J&J and AbbVie Hit New Highs

This article first appeared on GuruFocus. Healthcare stocks outperformed the broader market on Friday, with Eli Lilly (NYSE:LLY), Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV) among the major names hitting fresh 52-week highs. The se…

seekingalpha.comPOSITIVO

Lilly, J&J, AbbVie hit new 52-week highs as healthcare outperforms

[Wall Street Stock Market] meshaphoto/E+ via Getty Images Healthcare was a notable outperformer on Wall Street on Friday as several top sector components of the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]), including Eli Lilly (…

finance.yahoo.comPOSITIVO

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?

Vanguard Health Care ETF (NYSEMKT:VHT) provides broad-spectrum medical sector exposure at a low cost, while VanEck Pharmaceutical ETF (NASDAQ:PPH) offers concentrated exposure to global pharmaceutical giants with a higher yield. Investors…

finance.yahoo.comPOSITIVO

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global obesity rate has nearly tripled since…

seekingalpha.comPOSITIVO

AI-linked ETFs tumbled in Friday's tech selloff after months of outsized gains

[ETF investment money] zimmytws/iStock via Getty Images AI-linked ETFs were among the hardest-hit thematic funds during Friday's technology selloff, as investors dumped semiconductor and AI-related stocks following a Broadcom-driven rout a…

finance.yahoo.comPOSITIVO

Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF

One of the biggest misconceptions about ETFs is that they are highly diversified “baskets” of stocks. Sometimes they are. But as the iShares US Pharmaceuticals ETF (IHE) indicates, even with 60 stock holdings and $1 billion in assets, larg…

finance.yahoo.comPOSITIVO

Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.

Healthcare remains a cornerstone of many long-term portfolios, offering a mix of defensive stability and growth potential through innovation. Investors must decide whether to cast a wide net across the entire sector with a fund like the Fi…

finance.yahoo.comPOSITIVO

PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem

The VanEck Pharmaceutical ETF(NASDAQ:PPH) provides targeted exposure to drug manufacturers, while the iShares Global Healthcare ETF(NYSEMKT:IXJ) offers a broader reach across the international medical industry including biotechnology and e…

seekingalpha.comPOSITIVO

US Customs processing $20.6B in importer tariff refunds: report

[100 US dollar note on a USA flag with word TARIFFS] Tomas Ragina/iStock via Getty Images Approximately $20.6B is on its way to importers who successfully filed claims using the new web portal developed by US Customs and Border Protection,…